| abstract |
The present invention provides compounds of formula (I), enantiomers, diastereomers thereof, racemic mixtures thereof, prodrugs, crystalline forms, amorphous forms, amorphous forms thereof, solvates thereof, metabolites thereof and pharmaceutically acceptable salts. :n n n Formula In n n n n n n n Wherein the substituents of ring A are fully defined herein. The compounds of formula (I) are inhibitors of metalloproteinases such as matrix metalloproteinases and shadases and are useful in all diseases in which rheumatoid arthritis, psoriasis, neoplastic diseases, allergies and inhibition of MMP are desired. |